| SESSION |
TOPIC |
SPEAKER |
OVERVIEW |
PRESENTATION |
| DAY
ONE |
| 1 |
Recognising Individuality through
Insurance |
|
|
Not Available |
| 2 |
Industry Views on the
Implementation of the Private Health Insurance Reforms |
Hon Dr Michael Armitage,
Chief Executive Officer, AHIA |
The impending reforms
to the Private Health Insurance legislation are potentially
the most significant changes to the delivery of healthcare
in Australia in several decades. It is clear that the
manner in which the reforms are implemented by different
industry sectors will determine the eventual value of
the reforms to the Australian health consumer.
This session will
provide an opportunity for varied Industry Sectors to
discuss what they see as the outcomes of the implementation
of the reforms.
|
TBA |
Ms Christine Gee, President APHA |
|
Dr Mukesh Haikerwal, President, Australian
Medical Association |
TBA |
Mr David Meldrum, CEO Advanced Community
Care Association |
|
| 3 |
Making Sense of Consumer
Research |
Mr Tony Quint, General Manager, IPSOS
|
|
|
Ms Samantha Gavel, Acting Private Health Insurance
Ombudsman
|
|
Mr Mark Textor, Principal, Crosby Textor
|
TBA |
| 4 |
New Technologies and Challenges |
Prof Ian Olver, Chief Executive Officer, The Cancer
Council Australia
|
Consumers are becoming
more and more demanding of the health care system as
technology becomes more sophisticated. Increasingly
available expertise and modern therapies are leading
to an impending dramatic rise in costs over the horizon.
This session will
examine the science behind some of the medical advances,
and will provide an opportunity to gauge the cost implications
for consumers, the Government, and the whole health
sector.
|
|
Prof Stephen Graves, Director, National Joint Replacement
Registry
|
|
Prof Simon Stewart,
Head of the Preventative Cardiology Division of the
Baker Heart Institute |
|
| 5 |
Giving Back to the Community
- Health Fund Foundations |
Prof Robert Graham,
Executive Director, Victor Chang Cardiac Research Institute;
Head, Molecular Cardiology Program; Des Renford Professor
of Medicine, University of New South Wales |
A
number of private health insurers have established entities
with the aim of funding and promoting health and medical
research in Australia.
The ahm Health and
Medical Research Fund, the HCF Health and Medical Research
Foundation and the MBF Foundation have all been established
with the aim of funding and supporting Australian health
and medical research, the outcomes of which are designed
to benefit not only those with Private Health Insurance
but the community as a whole.
Research funding
commitments in excess of $10m have been made by these
organisations in the last twelve months. Speakers on
the program are all researches whose work has benefited
from funding and support provided by these organisations. |
Stem Cells
for Heart Disease: hype or hope?
(14
MB ppt)
|
Prof Johanna Westbrook, Deputy Director,
Centre for Health Informatics, University of New South
Wales |
Clinical Errors: Their
Causes and Frequency in Australian Hospitals
(2
MB ppt)
|
|
dNet Work
Centre
(235
KB ppt)
|
DAY
TWO |
| 6 |
Generation X and Generation Y - Their
Hot Buttons |
Ms Avril Henry, AH Revelations |
|
Not Available |
| 7 |
An Investment Outlook for
the Healthcare Sector: Analysts' Corner |
Mr John Goss, Principal
Economist, AIHW |
Healthcare spending - Private
Health Insurance in perspective
As important a component
as it is, Private Health Insurance remains a relatively
small and constricted source of funding Australia burgeoning
healthcare expenditure. In fact, its relative role has
actually declined in recent years notwithstanding increased
PHI participation within the population.
This session will
examine trends in healthcare expenditure and possible
implications for private funding and PHI insurers.
|
(812
KB ppt)
|
Mr Jon Gidney, JP Morgan Managing
Director Investment Banking, JP Morgan |
This Creature Called Mutuality
For an industry dominated by
mutual corporations, there is surprisingly little
discourse around the ongoing relevance of this structure.
This session will face the
history and rationale behind mutuality, the pros and
cons of mutuality and discuss why and how many companies
have sought to demutualise.
|
(236
KB ppt)
|
| 8 |
Quality and Safety |
Dr Diana Horvath AO,
Chief Executive Officer, Australian Commission on Safety
and Quality in Health Care |
Quality
in Healthcare has traditionally involved processes such
as accreditation, and risk management through systems
and activities focused on limiting adverse events. Whilst
addressing the human and financial costs of adverse
events is an industry priority, it is also time for
us to look at the quality of health care from a value
perspective - is the care appropriate and effective?
This session addresses
the challenge for the industry to move to a more long
term quality approach that ensures the investment in
health care delivers better health outcomes. |
|
Dr Andrew Vallance-Owen, Deputy
Chairman of the BUPA Foundation and the BUPA's Group
Medical Director |
|
Prof Guy Maddern, Australian
Safety and Efficacy Register of New Interventional Procedures
- Surgical (ASERNIPS-S), Adelaide and Department of
Surgery, University of Adelaide |
TBA |